Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Presentation
Patrick Hurban, Ph.D. | March 07, 2017

Genomic Assays for Clinical Development: Identifying the Right Solution from a Wealth of Potential Approaches

Molecular Medicine Tri-Conference 2017 Podium Presentation
Presented at Molecular Medicine Tri-Conference 2017, this presentation provides an overview of how genomic assays can be effectively implemented in clinical development. With careful consideration of the result and desired insights, several different genomic analysis and technologies can be utilized to design and execute smarter trials. 

Download this presentation to learn how we take a deeper dive into how large panel target enrichment, immune profiling, and HLA analysis are being used in clinical development. Q2 Solutions offers a range of genomic services to support drug discovery, precision medicine and clinical development. Our industry-leading genomic services team can help you uncover valuable insights from your genomic data. Through carefully orchestrated analyses, we work with you to choose platforms and assays that will distinctly fit your needs, and then use them to deliver valuable, informative data.

Speaker:
Patrick Hurban, Ph.D., Senior Director and Global Head, Translational Genomics

Related Services:
Genomic Know-How® for your drug development needs

Learn more about our genomic services

Planning and implementing biomarker testing for immuno-oncology trials

Exploring the challenges with the diverse clinical biomarker requirements

Translating Data into Insights with Bioinformatics

Read More